12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Quest Diagnostics sales and marketing update

Quest launched two blood tests in the U.S. to aid in diagnosing early stage rheumatoid arthritis. The tests are based on the 14-3-3n marker, to which Quest has exclusive,...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >